GlassScriptPhysician profile
Jonathan M Zuniga
NPI 1831167212
$177.25
in general payments reported to CMS, 2019-2025
4 companies · $13.06 in 2025
The $13.06 reported for 2025 was less than what a typical Nephrology (Internal Medicine) provider received nationally (typical 2025 total: $311).
See the full distribution for Nephrology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $18.20 · 2023: $110 · 2024: $35.66 · 2025: $13.06.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $128 · Food and Beverage: $31.28.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $127.77 |
| Food and Beverage | $31.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Opko Pharmaceuticals, LLC | $116.02 | 2022-2024 | Rayaldee |
| Travere Therapeutics, INC. | $29.95 | 2024-2025 | Filspari |
| Otsuka America Pharmaceutical, INC. | $17.52 | 2023 | Jynarque |
| Ardelyx, INC. | $13.76 | 2023 | Ibsrela |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Zuniga listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.